MedTrace Logo

Trial Investigating the Characteristics of Knismesis - a Lever to Explore Allodynia in Neuropathic Pain

NCT04621747 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2021-12-02

No results posted yet for this study

Summary

Also known as a "moving itch", knismesis is a mildly annoying sensation caused by a light movement on the skin, such as from a crawling insect. Its underlying mechanism rely on spatial summation, i.e. amplification of the signal due to summation of stimulated fields, like it is for dynamic allodynia in neuropathic pain. This physiological study aims at determining the physical factors of the cutaneous stimulation inducing knismesis as well as the effect of confounding factors. The main area of exploration will be the back, because of its size and the possibility to blind the participant. The information collected, along with animal data in surrogate models, would help to better understand neuropathic pain in the future.

Conditions

  • Healthy

Interventions

OTHER

Battery of neurophysiological explorations

Visit 1: Biometry collection: gender, age, weight, height, eye colour. * Questionnaires : the State and Trait Anxiety Inventory and the Pain Sensitivity * Threshold of unpleasant light brightness, mechanical sensitivity threshold (von Frey hair). * Training to estimate unpleasantness Under nociceptive and tickling stimuli, to use the handgrip. * Mechanical pain threshold (electronic von Frey), heat pain threshold (Medoc Pathway). * 48 stimulations applied to the back skin, following a predetermined plan with 12 different pathways, imbricated with 4 different speeds of movement. Visit 2 (1 to 8 days later) : * 42 stimulations applied to the back skin, to test the effect of stimulation intensity, the side of application, continuity break of the contact, and distraction by other cutaneous stimuli. The stimuli will follow the best paradigm as identified at the previous visit. * 12 stimulations applied to forearm, cheeks, lower limbs, also testing the effect of hairiness.

Sponsors & Collaborators

  • NEURO-DOL (UMR 1107 INSERM / UCA)

    collaborator UNKNOWN

  • University Hospital, Clermont-Ferrand

    lead OTHER

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-23
Primary Completion
2022-12-01
Completion
2022-12-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04621747 on ClinicalTrials.gov